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In 21 nurses (34.4∫3.9 yr), VO2max, physical activity,
body composition and lifestyle parameters were measured
to determine which of these characteristics are related to
metabolic and hemostatic risk for cardiovascular disease.
Physical activity was assessed with the 7-day recall inter-
view. VO2max was measured in a progressive and continu-
ous treadmill test to volitional fatigue. Fasting insulin,
total cholesterol, HDL-C, triglycerides, fibrinogen, tPA-
Over the past few decades, numerous studies have
been published evaluating the relationship between
physical activity and cardiovascular health, primarily
in middle-aged and older men. The main outcome
of these studies is that risk for the development of
cardiovascular disease (CVD) seems to be reduced in
physically active individuals versus their sedentary
counterparts (Berlin & Colditz 1990, Powell et al.
1987). Increased physical activity is thought to pro-
vide cardioprotection, amongst others, by modifying
several metabolic and hemostatic cardiovascular risk
indicators. More favorable plasma lipid and lipopro-
tein profiles (Durstine & Haskell 1994, Kokkinos et
al. 1995, Wood et al. 1991) have been reported in
physically active compared with inactive persons.
Physical activity lowers fasting insulin levels (Seals et
al. 1984), blood pressure (Fletcher et al. 1992, Kok-
kinos et al. 1994), plasma fibrinogen (DeSouza et al.
1997), and improves fibrinolytic function, as evi-
denced by lower tissue-type plasminogen activator
antigen (tPA-ag) and plasminogen activator inhibitor
type 1 antigen (PAI-1-ag) (Ferguson et al. 1987, Stev-
enson et al. 1995, Wheeler et al. 1986).
Largely the same beneficial effects have been attri-
buted to aerobic fitness, defined as the maximal oxy-
gen consumption (VO2max). High fit subjects have a
more favorable metabolic and hemostatic risk profile
than low fit subjects (Kokkinos et al. 1995, Anders-
en & Haraldsdottir 1995, DeSouza et al. 1998, Gib-
bons et al. 1983, Szymanski et al. 1996). Although
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act, tPA-ag, and PAI-1-ag were determined from fasting
blood samples. Contrary to our expectation, there was no
association of physical activity with any of these risk indi-
cators. High VO2max was associated with lower levels of
insulin and fibrinogen. Regression analyses indicated that
metabolic and hemostatic risk indicators, as measured in
healthy premenopausal nurses, were mainly predicted by
waist circumference and oral contraceptive use.
individual differences in VO2max are partly deter-
mined by physical activity behavior, they may largely
reflect genetic endowment (Malina & Bouchard
1989). Heritabilities of 51–78% have been reported
for VO2max (Bouchard et al. 1998, Fagard et al. 1991),
and at least 80% of fitness was found not to be ex-
plained by physical activity (Katzmarzyk et al. 1998).
It is unclear to what extent the beneficial effects of
physical activity and high aerobic fitness are overlap-
ping (Andersen 1995). If they are independent, these
effects could be additive or even synergistic.
To complicate matters, low levels of physical activ-
ity and aerobic fitness are usually associated with
high levels of total body and abdominal fat (Wood et
al. 1991, Andersen et al. 1998, Jette et al. 1992). At
the same time, obese subjects are known to have an
unfavorable metabolic and hemostatic profile, that
may in part be a consequence of abdominal fat itself
and the underlying insulin resistance (Lindahl et al.
1996). Therefore, body composition may be an over-
lapping factor underlying part of the associations of
physical activity and aerobic fitness with CVD risk
indicators.
The majority of the studies on physical activity and
aerobic fitness have been conducted in men. However,
CVD is not only the leading cause of death in men,
but also in women (LaCroix 1995). The effects of aer-
obic fitness and physical activity on metabolic and
hemostatic risk indicators in women have been sel-
dom studied, and the findings have been equivocal
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(Powell et al. 1987). In addition, most of the studies
measured heterogeneous populations of both post-
menopausal and premenopausal women or failed to
take oral contraceptive use (OC-use) or stage in the
menstrual cycle into account (Kokkinos et al. 1995,
Andersen & Haraldsdottir 1995, DeSouza et al. 1998,
Gibbons et al. 1983). The present study examined the
relationship between directly measured VO2max, body
composition, physical activity and metabolic and
hemostatic risk indicators in healthy female nurses.
OC-use was used as a covariate in all analyses. It was
hypothesized that high levels of physical activity and
aerobic fitness and low levels of body fat are indepen-
dently associated with a more favorable metabolic
and hemostatic risk profile.
Material and methods
Subjects
Twenty-one female nurses participated in this study (mean age
34.4 yr; SDΩ3.9). Subjects were randomly selected from a
larger sample (nΩ159) of participants in an investigation of the
effects of work stress on risk indicators of cardiovascular dis-
ease in female nurses. All of them were working on the same
shift in the same hospital in the city of Amsterdam. Only
healthy subjects, who were not receiving treatment or taking
medication for hypertension, cerebrovascular disease, hyperlipi-
demia and/or diabetes mellitus, were included. Among the sub-
jects were five cigarette smokers (maximum of 15 cigarettes a
day). Subjects were briefed as to the nature, purposes and risks
of the study. Those electing to participate gave their written
informed consent. The study was approved by the Ethics Com-
mittee of the Vrije Universiteit of Amsterdam.
Procedure
Blood samples were collected at the workplace before starting an
early shift between 7:00 and 7:30 a.m. Blood samples were drawn
on two days of the same early shift. The first sample was taken on
the first day of the early shift, the second sample on the third day
of that same shift. Subjects were requested to fast and refrain
from use of alcohol, coffee and tea after 11:00 p.m. the preceding
night and to refrain from moderate or severe physical activity the
preceding day. The blood was drawn from the arm in an upright
sitting position after at least 15 min rest. The vacutainer blood
withdrawal system was used for collecting the blood samples.
Measured parameters were: fasting insulin, total cholesterol
(TC), high-density lipoprotein (HDL-C), triglycerides (TG), fi-
brinogen, tissue-type plasminogen activator activity (tPA-act),
tissue-type plasminogen activator antigen (tPA-ag), and plas-
minogen activator inhibitor type I antigen (PAI-1-ag). Blood
pressure was measured twice by a calibrated SpaceLabs 90207
ambulatory blood pressure monitor (SpaceLabs Medical,
Redmond, USA) after 10 min quiet resting.
Blood handling and biochemical assays
Blood withdrawal was according to the Standardized European
Concerted Action on Thrombosis (ECAT) assay procedures
(Kluft & Meijer 1996, Walker 1992). Blood was drawn by veni-
puncture of the antecubital vein, while the subject was seated,
and sampled in six different vacutainers in the following order:
serum (3 ml), serum with clot-activator (5 ml), stabilyte (5 ml),
citrate (5 ml), EDTA (3 ml), NaF (2 ml). For determination of
TC, TG and HDL-C, the serum with clot-activator was used.
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Blood was allowed to clot for minimal 30 min and maximal 2
h at room temperature. Serum was separated by centrifugation
at 2000¿g for 20 min at 4æC. Lipid determinations were per-
formed on the same day using the Vitros 250 Clinical Chemis-
try analyzer (Johnson & Johnson, Rochester, USA) with Vitros
clinical chemistry slides for TC and TG. High-density chol-
esterol (HDL) was measured in serum after a precipitation step
with HDL-C precipitant (Boehringer Mannheim, Mannheim,
Germany). All lipid results are given as millimoles per liter
(mmol ¡ lª1).
Fasting insulin (pmol ¡ lª1) was measured with an immunora-
diometricassay kit (Medgenix Diagnostics Fleurus, Belgium) by
means of the serum-tube. Blood had to clot for minimal 60 min
at room temperature. Serum was separated by centrifugation at
2000¿g for 20 min at 4æC. Aliquots of serum were stored at
ª20æC. Values were multipled by 0.139 to convert fasting insu-
lin into milliunits per liter (mU ¡ lª1).
Stabilyte blood was collected for the determination of tPA-
act. Citrated blood was collected for the determination of PAI-
1-ag, tPA-ag and fibrinogen. Immediately after collection, the
tubes were put in melting ice and centrifugated within 60 min
(2000¿g, 20 min at 4æC). Aliquots of plasma were snap-frozen
immediately using solid carbon dioxide and stored at ª80æC.
tPA-act was measured using the bio-functional immunosorbent
assay ChromolizeTM tPA (Biopool, Umeå, Sweden). Results are
expressed in International Units per milliliter (IU ¡ mlª1). PAI-
1-ag was measured using the enzyme immunoassay Innotest
PAI-1 (Innogenetics, Zwijndrecht, Belgium). Results are ex-
pressed in nanograms per milliliter (ng ¡ mlª1). t-PA antigen was
measured using the enzyme immunoassay ImulyseTM tPA (Bi-
opool, Uneå, Sweden). Results are expressed in nanograms per
milliliter (ng ¡ mlª1). Fibrinogen was measured using the STA
coagulation analyzer (STAGO, Asnie`res, France) and the STA
Fibrinogen kit (Boehringer Mannheim, Mannheim, Germany).
The results are expressed in grams per liter (g ¡ lª1).
The intra-assay and inter-assay coefficient of variation were
less then: 5.0% and 7.0% for fasting insulin, 4.0% and 6.0% for
TC, 3.5% and 5.0% for HDL, 3.0% and 5.0% for TG, 7.5% and
10% for tPA act, 10% and 10% for PAI-1-ag, 10% and 12%
for tPA-ag, 5% and 7% for fibrinogen. For each of the blood
parameters, all 42 blood samples were analyzed in the same
batch. Moreover, the blood samples, drawn from the same sub-
jects on repeated blood withdrawal occasions, were analyzed
simultaneously on the same plate. No sample had been stored
for more than 7 months.
Laboratory testing
Preceding exercise testing, a detailed medical history was taken
by interview. The subjects were asked about their age, medi-
cation, use of oral contraceptives, stage in the menstrual cycle,
smoking habits, and alcohol consumption. Current smoking
habits were assessed by self-report as number of cigarettes
smoked per day, but the variable was recoded into smokers and
nonsmokers in the statistical analyses. The average weekly alco-
hol intake was assessed by the number of glasses consumed per
week. Assessment of the subject’s physical activity pattern dur-
ing a (normal) week (kJ ¡ kgª1 ¡ dª1) was obtained by a Dutch
modified version of the 7-day activity recall interview (Blair et
al. 1985), as used by De Geus et al. (1993). Anthropometric
measurements taken included body height, body weight, body
mass index (BMI), waist and hip circumference. The measure-
ments were taken while the subjects were wearing only light
clothing. Body height was measured to the nearest centimeter,
with subjects standing on a hard surface against a wall, using
a square and tape measure fixed to the wall. Body weight was
measured to within 100 g using a calibrated digital scale. BMI
was calculated as the weight in kilograms divided by the square
of height in meters. Waist circumference was measured at the
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end of a normal expiration. A measuring tape was positioned at
the level of noticeable waist narrowing with the subject standing
erect. Hip circumference was measured with the tape positioned
at the level of the symphysis pubis and the greatest gluteal pro-
tuberance. Measurements were recorded to the nearest 0.5 cm.
The waist and hip circumference were used to compute the
WHR (waist circumference/hip circumference) as an estimate of
abdominal fat distribution.
Maximal oxygen consumption (VO2max) was measured by a
progressive and continuous test to volitional fatigue on a mo-
torized treadmill (Quinton model 65, Seattle, USA). The sub-
jects were instructed not to eat a large meal for at least 3 h
preceding the test and to refrain from moderate or severe exer-
cise in the 24-h period preceding the test. Subjects were fitted
with a short-range radiotelemeter (Sport Tester PE 3000, Fin-
land) for heart rate measurements. After familiarization with
the laboratory environment and testing procedures, the test be-
gan with a 5-min warm-up at 0% inclination during which the
speed was increased gradually to the protocol’s respective run-
ning speed. The subjects were instructed to select a speed that
felt comfortable and would allow a maximal effort within 15
min. The mean selected speed was in a range of 8–10 km ¡ hª1
and this speed was maintained throughout the test. Throughout
the test, the inclination was raised 2.5% every 3 min until voli-
tional fatigue was reached. Subjects were motivated verbally to
continue as long as possible until they could no longer continue
running at the indicated speed. Subjects were not allowed to
use the handrails. Respiratory measurements were obtained
using an Oxycon Spirometer (Mijnhardt, The Netherlands),
which was calibrated against two gas mixtures before each test.
Oxygen uptake (VO2), carbon dioxide concentrations (VCO2),
and the respiratory exchange ratio (RER) were computed and
updated every 30 s of the test. Even though all subjects were
encouraged to run to exhaustion, the attainment of VO2max was
accepted only when all 3 of the following criteria were met: (1)
Table 1. Subject characteristics
Variable Mean (nΩ21) SD Range
Age, years 34.4 3.9 29–41
Body composition
Height, cm 170.2 4.6 162–180
Weight, kg 70.8 13.5 51.1–108.8
Waist circumference, cm 76.6 11.2 65.0–110.0
BMI, kg ¡ mª2 24.43 4.61 19.31–38.39
WHR 0.78 0.03 0.71–0.87
Smokers, n (%) 5 (24)
OC-use, n (%) 10 (48)
Blood parameters
Fasting insulin, mU ¡ lª1 7.35 2.31 4.24–13.72
TC, mmol ¡ lª1 4.73 0.99 3.34–7.24
Triglycerides, mmol lª1 1.01 0.28 0.61–1.65
HDL-C, mmol lª1 1.57 0.38 0.97–2.43
Fibrinogen, g ¡ lª1 3.00 0.61 2.06–4.30
tPA-act, IU ¡ mlª1 0.74 0.33 0.20–1.38
tPA-ag, ng ¡ mlª1 4.67 2.07 1.98–9.21
PAI-1-ag, ng ¡ mlª1 45.34 42.69 6.10–142.22
Cardiorespiratory fitness
Resting systolic blood pressure, mmHg 125.52 11.87 105.00–153.00
Resting diastolic blood pressure, mmHg 74.02 12.82 50.00–95.50
VO2max, ml ¡ minª1 ¡ kgª1 35.0 4.4 27.2–42.9
Physcal activity, kJ ¡ kgª1 ¡ dª1 200.4 21.0 163.6–252.5
BMI indicates body mass index; WHR, waist-hip ratio; OC-use, use of oral contraceptives; TC, total cholesterol; HDL-C, high-density lipoprotein
cholesterol; tPA-act, tissue-type plasminogen activatory activity; tPA-ag, tissue-type plasminogen activator antigen; PAI-1-ag, plasminogen activator
inhibitor type 1 antigen.
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a plateau of VO2 with increasing work rate, (2) a respiratory
exchange ratio of 1.0 or higher, and (3) a heart rate within 10
beats per minute of age-predicted maximum heart rate.
Statistical analysis
Pearson correlation coefficients and multiple stepwise re-
gression analyses (SPSSwin version 7.5) were used for statistical
evaluations. In the multiple regression models, fasting insulin,
TC, HDL-C, TG, fibrinogen, tPA-act, tPA-ag, PAI-1-ag, sys-
tolic blood pressure and diastolic blood pressure were used as
dependent variables. VO2max, physical activity, body compo-
sition, age, alcohol use, smoking habits and OC-use were used
as independent variables. The P∞0.05 level of significance was
applied to all tests.
Results
All data were checked with regard to frequency distri-
bution. Since fasting insulin and PAI-1-ag were not
normally distributed in this sample, these variables
were logarithmically transformed prior to analysis to
normalize their skewed distribution. Mean values,
standard deviations and ranges of anthropometrics,
blood parameters, self-reported physical activity and
VO2max are presented in Table 1. For readability, the
original untransformed values are given.
Table 2 shows Pearson’s correlation coefficients
among the blood parameters, age, OC-use, waist cir-
cumference and VO2max. VO2max was negatively associ-
ated with fasting insulin (rΩª0.56, P∞0.000) and fi-
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brinogen (rΩª0.58, P∞0.000). No significant corre-
lation was found between physical activity and any of
the risk indicators or between physical activity and
VO2max. In addition, no significant correlation be-
tween stage in the menstrual cycle, smoking habits or
alcohol use was found with any of the risk indicators.
BMI (rΩ0.93, P∞0.000) and WHR (rΩ0.75, P∞0.000)
showed high correlation with waist circumference and
the risk indicators. However, of these three measures
of body composition, waist circumference showed the
highest correlations with the risk indicators. Only age,
OC-use, waist circumference and VO2max were retained
for the regression analyses below.
Multiple regression analyses (stepwise) revealed
that OC-use was the best predictor of HDL-C, TG,
tPA-act and PAI-1-ag level, explaining respectively
19.2%, 32.6%, 41.7% and 34.0% of the variance
(Table 3). Waist circumference and age explained
68.8% of the variance in plasma fibrinogen level.
Waist circumference and VO2max explained 50.1% of
the variance in tPA-ag level. VO2max was the best pre-
dictor of fasting insulin, explaining 31.7% of the vari-
ance in fasting insulin levels.
Discussion
The primary finding of this study is that the metabolic
and hemostatic risk profile observed in a population of
premenopausal healthy women appears to be pre-
dicted mainly by their waist circumference and OC-
use. VO2max was associated with fasting insulin and fi-
brinogen, but not independently from waist circumfer-
ence. No associations were found between physical ac-
tivity habits and any of the CVD risk indicators.
The metabolic and hemostatic risk indicators
examined in the current study are known to belong
to a multiple risk factor syndrome, referred to as syn-
drome X or the insulin resistance syndrome (Reaven
1994). This syndrome refers to a clustering of CVD
risk indicators that has been observed primarily in
middle-aged and older people. It includes hyperlipid-
emia, hyperinsulinemia and insulin resistance, excess
abdominal fat and inadequate fibrinolysis. Although
we examined a healthy population, the usual pattern
of correlations between these risk indicators was evi-
dent. For instance, the relation between insulin levels
and waist circumference, earlier observed in a larger
survey of premenopausal women (Seidell et al. 1990),
was confirmed. The significant relation in this study
between tPA-act, an important stimulator of fibrino-
lysis, and the cardioprotective HDL-C repeats the
finding of Szymanski et al. (1996). High correlations
were found between waist circumference and indi-
cators of the hemostatic system, again in line with
other studies (DeSouza et al. 1998, Andersen et al.
1998, Siegbahn & Ruusuvaara 1988).
Surprisingly few studies have been done on VO2max
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Table 3. Multiple regression analyses (stepwise) of cardiovascular risk indicators
Variable Predictor 1 Beta coefficient P-value Predictor 2 Beta coefficient P-value Total R2
Fasting insulin VO2max ª0.563 0.008 0.371
TC*
HDL-C OC-use 0.438 0.047 0.192
Triglycerides OC-use 0.571 0.007 0.326
Fribrinogen Waist 0.685 0.000 Age ª0.434 0.004 0.688
tPA-act OC-use 0.646 0.002 0.417
tPA-ag Waist 0.922 0.001 VO2max 0.477 0.044 0.501
PAI-1-ag OC-use ª0.583 0.005 0.340
Systolic BP*
Diastolic BP*
TC indicates total cholesterol; HDL-C, high-density lipoprotein cholesterol; tPA-act, tissue-type plasminogen activator activity; tPA-ag, tissue-type
plasminogen activator antigen; PAI-1-ag, plasminogen activator inhibitor type 1 antigen; OC-use, use of oral contraceptives; Waist, waist circumference.
Total R2 is cumulative variance explained by all significant predictors.
* No significant predictors.
and metabolic risk indicators in women. In studies on
large groups of young women, TC (Andersen & Har-
aldsdottir 1995, McMurray et al. 1998) and TG (And-
ersen & Haraldsdottir 1995) were inversely associated
with VO2max. Two studies on both pre- and post-
menopausal women, using treadmill time as a determi-
nant of fitness levels, found a positive and significant
relationship between HDL-C and fitness levels, and a
negative relationship between TG and fitness levels, in-
dependent of age and weight (Kokkinos et al. 1995,
Gibbons et al. 1983). In training studies in women
(Duncan et al. 1991, Hardman et al. 1989, Hill et al.
1989), higher levels of HDL-C were found after a
period of severe exercise training. Recent reviews in this
area point to the importance of blood sampling during
the same phase of the menstrual cycle and accounting
for the use of oral contraceptives (Krummel et al. 1993,
Taylor & Ward 1993). Correlational studies on lipids
and aerobic fitness in women often failed to correct for
oral contraceptive status (Kokkinos et al. 1995). The
three training studies reporting a positive influence of
exercise on HDL-C controlled for the phase of the
menstrual cycle during blood sampling (Duncan et al.
1991, Hardman et al. 1989, Hill et al. 1989) but the
number of subjects using oral contraceptives was not
reported. In the current study, the menstrual status of
the women had no impact on the risk indicators, but
the results of our multiple regression analyses indicate
that OC-use was responsible for a significant portion
of the explained variance in the plasma levels of HDL-
C and TG of healthy premenopausal women.
OC-use was also the main determinant of the fi-
brinolytic indicators. PAI-1-ag and tPA-ag levels cor-
related negatively with OC-use, whereas tPA-act was
positively associated with OC-use. Elevated levels of
plasma PAI-1-ag, tPA-ag and reduced tPA-act sug-
gest lower fibrinolytic capacity and have been associ-
ated with myocardial reinfarction and CVD mortality
(Jansson et al. 1991, Jansson et al. 1993). Our data
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suggest higher fibrinolytic capacity and reduced CVD
risk in women using oral contraceptives. The cur-
rently available studies on fibrinolysis and OC-use are
conflicting. Although higher tPA-act in plasma of
OC-users has been detected before (Quehenberger
1993) and OC-use has been suggested to enhance tPA
synthesis (Siegbahn & Ruusuvaara 1988), others have
found no significant effects of OC-use on tPA-act (De
Paz et al. 1995). For tPA-ag, OC users have been
found to have either elevated levels (Siegbahn &
Ruusuvaara 1988) or comparable levels to non-OC
users (De Paz et al. 1995), both of which contrasts
with the lower levels of tPA-ag observed in the pres-
ent study. A reduction of plasma PAI-1-ag appears to
be the most robust finding in OC-users. The inverse
relationship between circulating PAI and OC-use
found in the present study is in accordance with pre-
vious reports (Siegbahn & Ruusuvaara 1988,
Quehenberger et al. 1993, De Paz et al. 1995). It has
been assumed that the decrease of circulating PAI is
due to the inhibitory effects of OC on PAI produc-
tion and release from the endothelial cells (Sieg-
bahn & Ruusuvaara 1988, Kluft & Lansink 1997).
Several epidemiological studies have reported that
the excess body fat associated with obesity is a sig-
nificant and independent risk indicator for CVD and
related mortality (Coleman et al. 1992, Hubert et al.
1983). However, methods used to define obesity have
often referred to excess weight rather than excess fat
by measuring BMI. BMI does not provide a direct
measure of adiposity or fatness but is a measure of
proportional weight. Recent reports indicate that
body fat distribution is more predictive of metabolic
and cardiovascular diseases than BMI (Despres &
Lamarche 1993, Despres et al. 1990). Most often the
WHR has been used as an estimate of body fat distri-
bution, but waist circumference by itself may be even
more strongly associated with risk indicators (And-
ersen et al. 1998, Seidell et al. 1990, Ledoux et al.
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1997). Seidell and colleagues (1990) reported that in
women, waist circumference was significantly corre-
lated with TC, HDL-C, TG, fasting insulin and dias-
tolic blood pressure. Stevenson and co-workers (1995)
showed that waist circumference was a better predic-
tor of plasma levels of PAI-1-ag, tPA-ag, TG and
lipoproteins than percent total body fat or WHR. In
agreement with these studies, we found that waist cir-
cumference showed stronger associations than BMI
and WHR with all risk indicators studied.
Both waist circumference and VO2max were signifi-
cantly correlated with plasma fibrinogen and fasting
insulin level. After partialling out waist circumfer-
ence, the primary determinant of fibrinogen, no ad-
ditional effect of VO2max on fibrinogen was found. In
the same way, after partialling out VO2max, the pri-
mary determinant of insulin, the correlation between
waist circumference and insulin disappeared. Similar
findings have been reported in a group of pre- and
postmenopausal women (DeSouza et al. 1998). Insu-
lin and fibrinogen are themselves correlated but the
mechanism behind the correlation (Lindahl et al.
1996, Juhan-Vague et al. 1993) is poorly understood.
Insulin resistance mediated free fatty acid release may
be involved because this is accompanied by a rise in
plasma fibrinogen levels (Pickart & Thaler 1980).
Since it becomes increasingly apparent that adipocyt-
es, besides being a fat storage cell, may synthesis and
secrete a number of proteins e.g. fibrinogen (Losku-
toff & Samad 1998), our data suggest that the favor-
able association between plasma fibrinogen levels and
aerobic fitness may actually be mediated by a smaller
amount of abdominal fat in highly fit subjects. Defi-
nite causality of aerobic fitness and body fat effects
on insulin and fibrinogen remains to be established.
Neither physical activity status nor aerobic fitness
level had any effect on PAI-1-ag, tPA-ag and tPA-act
in the premenopausal women in this study. In accord-
ance with our results, DeSouza et al. (1998) reported
no differences in tPA-ag and tPA-act. However, they
did find reduced levels of PAI-1-ag in physically active
compared with sedentary premenopausal women,
who also differed significantly in VO2max. Based on
their results, DeSouza et al. (1998) concluded that
age-related changes in the fibrinolytic system may not
be a primary effect of aging but that such changes
may be due to reductions in physical activity or aer-
obic fitness and associated increases in body weight
and fatness. This is in accordance with our findings:
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